Randall E. Kaye
2022
In 2022, Randall E. Kaye earned a total compensation of $1.4M as Executive Vice President and Chief Medical Officer at Longboard Pharmaceuticals.
Compensation breakdown
Non-Equity Incentive Plan | $198,000 |
---|---|
Option Awards | $827,115 |
Salary | $351,563 |
Other | $9,150 |
Total | $1,385,828 |
Kaye received $827.1K in option awards, accounting for 60% of the total pay in 2022.
Kaye also received $198K in non-equity incentive plan, $351.6K in salary and $9.2K in other compensation.
Rankings
In 2022, Randall E. Kaye's compensation ranked 2,395th out of 5,736 executives tracked by ExecPay. In other words, Kaye earned more than 58.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,395 | 58th |
Manufacturing | 1,318 | 58th |
Chemicals And Allied Products | 589 | 58th |
Drugs | 544 | 59th |
Pharmaceutical Preparations | 394 | 59th |
Kaye's colleagues
We found two more compensation records of executives who worked with Randall E. Kaye at Longboard Pharmaceuticals in 2022.